MedTrace Logo

The Effect of In-vitro Myoinositol Supplementation of Human Sperm on the Outcome of Cryopreservation

NCT03153436 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2017-05-16

No results posted yet for this study

Summary

The objective of this study is to evaluate the effect of in-vitro myoinositol supplementation of human sperm on the outcome of cryopreservation.

Conditions

  • Myoinositol
  • Cryopreservation
  • Human
  • Sperm

Interventions

BIOLOGICAL

Myoinositol

Sponsors & Collaborators

  • Ajyal Hospital

    collaborator OTHER

  • Sohag University

    lead OTHER

Principal Investigators

  • Ramadan Saleh, M.D. · Sohag University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-28
Primary Completion
2017-04-26
Completion
2017-04-26

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03153436 on ClinicalTrials.gov